(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics,  Pathogenesis, Vaccines & Drugs)

4137.   Alessio M. Cytoadherence of Plasmodium falciparum-infected erythrocytes is mediated by a redox-dependent conformational fraction of CD36. J Immunol  2001 Dec 1;167(11):6510-7

4138.   Amaral L, Viveiros M, Kristiansen JE. Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries. Trop Med Int Health  2001 Dec;6(12):1016-22

4139.   Arevalo-Herrera M, Herrera S. Plasmodium  vivax malaria vaccine development. Mol Immunol  2001 Dec;38(6):443-55

4140.   B, Gay F, Looareesuwan S. Association of splenomegaly with cerebral malaria and decreased concentrations of reactive nitrogen intermediates in Thailand. Am J Trop Med Hyg  2001 Nov;65(5):639-43

4141.   Basco LK, Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients. Am J Trop Med Hyg  2001 Dec;65(6):798-803

4142.   Bhat GP, Surolia N. In vitro antimalarial activity of extracts of three plants used in the traditional medicine of India. Am J Trop Med Hyg  2001 Oct;65(4):304-8 

4143.   Biswas R, Sengupta G, Mundle M: Controlled study  on haemograms of  malaria patients in Calcutta. Indian J Malar 1999, 36(1-2), 42-8. (015287) Aug 1, 2023

4144.   Bradbury J. Haemoglobin C protection against  malaria. Lancet  2001 Nov 17;358(9294):1702

4145.   Brice GT, Graber NL, Hoffman SL, Doolan DL. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-gamma production and IFN-gamma-secreting cells. J Immunol Methods  2001 Nov 1;257(1-2):55-69

4146.   Brower V. Tackling the most difficult diseases. Genetics and genomics open new strategies to fight vector-borne diseases. EMBO Rep  2001 Oct;2(10):875-7

4147.   Bryceson A. A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop Med Int Health  2001 Nov;6(11):928-34

4148.   Burgess DC, Kain KC. The performance and utility of rapid diagnostic assays for Plasmodium falciparum malaria in a field setting in the Lao People's Democratic Republic. Ann Trop Med Parasitol  2001 Oct;95(7):671-7

4149.   Chongsuphajaisiddhi T, White NJ. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg  2001 Nov;65(5):614-22

4150.   Cian F, Declich S. HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS  2001 Dec 7;15(18):2445-50

4151.   Corbellino M. Subacute malaria due to Plasmodium falciparum and the role of polymerase chain reaction. Clin Infect Dis  2001 Nov 1;33(9):1614-5

4152.   Cunha MG, Rodrigues MM, Soares IS. Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors. Vaccine  2001 Nov 12;20(3-4):385-96

4153.   D'Alessandro U, Buttiens H. History and importance of antimalarial drug resistance. Trop Med Int Health  2001 Nov;6(11):845-8

4154.   Foca A, Matera G, Barreca GS, Gagliardi F, Apuzzo G, Guaglianone L. Imported malaria in pregnancy due to Plasmodium falciparum. J Travel Med  2001 Nov-Dec;8(6):331-2

4155.   Goodman CA, Coleman PG, Mills AJ. Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs. Health Econ  2001 Dec;10(8):731-49

4156.   Gupta D, Chugh K, Sachdev A, Soni A. ICU management of  severe malaria. Indian J Pediatr  2001 Nov;68(11):1057-61

4157.   Haldar K, Samuel BU, Mohandas N, Harrison T, Hiller NL. Transport mechanisms in Plasmodium-infected erythrocytes: lipid rafts and a tubovesicular network. Int J Parasitol  2001 Oct;31(12):1393-401

4158.   Hemingway J. Identification of a novel class of insect glutathione S-transferases involved in resistance to DDT in the malaria vector Anopheles gambiae. Biochem J  2001 Oct 15;359(Pt 2):295-304

4159.   Kaushik A, Gahlot S, Kaushik  S, Verma B L. Rapid manual test for falciparum malaria. Indian Pediat 2001, 38(6), 650-4. (017313).1 Sept 2001.

4160.   Kawamoto F. Detection of Plasmodium ovale by the ICT malaria P.f/P.v. immunochromatographic test. Acta Trop  2001 Dec 21;80(3):283-4

4161.   Kirk K.  Malaria. A voracious creature. Lancet  2001 Dec;358 Suppl:S41

4162.   Krettli AU, Andrade-Neto VF, Brandao MG, Ferrari WM. The search for new antimalarial drugs from plants used to treat fever and malaria or plants ramdomly selected: a review. Mem Inst Oswaldo Cruz  2001 Nov;96(8):1033-42

4163.   L, Sergheraert C, Grellier P, Schirmer RH, Becker K. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem  2001 Nov 22;44(24):4268-76

4164.   Leke RG. The state of immunology in Africa: HIV/AIDS and malaria. Curr Opin Immunol  2001 Oct;13(5):523-7

4165.   Mayxay M, Chotivanich K, Pukrittayakamee S, Newton P, Looareesuwan S, White NJ. Contribution of humoral immunity to the therapeutic response in falciparum malaria. Am J Trop Med Hyg  2001 Dec;65(6):918-23

4166.   Merten M, Thiagarajan P. Role for sulfatides  in platelet aggregation. Circulation  2001 Dec 11;104(24):2955-60

4167.   Modiano D. Antimalarial  antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun  2001 Nov;2(7):411-4

4168.   Nacer A, Berry L, Slomianny C, Mattei D. Plasmodium falciparum signal sequences: simply sequences or special signals? Int J Parasitol  2001 Oct;31(12):1371-9

4169.   Oguariri RM, Borrmann S, Klinkert MQ, Kremsner PG, Kun JF. High prevalence of human antibodies to recombinant Duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in nonimmune children. Infect Immun  2001 Dec;69(12):7603-9

4170.   Okech BA, Nalunkuma A, Okello D, Pang XL, Suzue K, Li J, Horii T, Egwang TG. Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda. Am J Trop Med Hyg  2001 Dec;65(6):912-7

4171.   Olliaro P, Taylor WR, Rigal J. Controlling malaria: challenges and solutions. Trop Med Int Health  2001 Nov;6(11):922-7

4172.   Ouellette M. Biochemical and molecular mechanisms of drug  resistance in parasites. Trop Med Int Health  2001 Nov;6(11):874-82

4173.   Pennisi E. Genes and disease. Genetic change wards off malaria. Science  2001 Nov 16;294(5546):1439

4174.   Pinder M, Hill AV, Plebanski M.  Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays. J Immunol  2001 Oct 15;167(8):4729-37

4175.   Rajagopal  V, Appavoon N C, Sarangapani T D, Mani S: Comparative study on microscopic detection of malaria parasites under conventional thick film and concentration by saponin haemolysis.Indian J Malar 1999, 36(1-2), 49-51. (015249), Aug 1, 2023

4176.   Rajesh Kumar: Study of consequences of malaria among sicklers. Proc Indian Sci Congr Ass- Pt II, Sect- II 1999, 28-9. (016449). Aug 16, 2001.

4177.   Rhee MS, Akanmori BD, Waterfall M, Riley EM. Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin Exp Immunol  2001 Dec;126(3):503-10

4178.   Rowe AK, Onikpo F, Lama M, Cokou F, Deming MS. Management of childhood illness at health facilities in Benin: problems and their causes. Am J Public Health  2001 Oct;91(10):1625-35

4179.   Rubio JM, Berzosa PJ, Benito A. Amplified fragment length polymorphism (AFLP) protocol for genotyping the malarial parasite Plasmodium falciparum. Parasitology  2001 Oct;123(Pt 4):331-6

4180.   Saito-Ito A, Akai Y, He S, Kimura M, Kawabata M. A rapid, simple and sensitive flow cytometric system for detection of Plasmodium falciparum. Parasitol Int  2001 Nov;50(4):249-57

4181.   Senior K. "Imperfect" vaccines may encourage more potent pathogens, model suggests. Lancet  2001 Dec 15;358(9298):2055

4182.   Snounou G. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother  2001 Nov;45(11):3122-7

4183.   Tarimo DS, Minjas JN, Bygbjerg IC. Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change of treatment policy. Trop Med Int Health  2001 Dec;6(12):992-7

4184.   Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. Am J Trop Med Hyg  2001 Oct;65(4):309-17

4185.   Tjitra E, Suprianto S, Dyer ME, Currie BJ, Anstey NM. Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia. Am J Trop Med Hyg  2001 Nov;65(5):593-8

4186.   Toure FS, Mavoungou E, Ndong JM, Tshipamba P, Deloron P. Erythrocyte binding antigen (EBA-175) of Plasmodium falciparum: improved genotype determination by nested polymerase chain reaction. Trop Med Int Health  2001 Oct;6(10):767-9

4187.   Trial Team. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet  2001 Dec 8;358(9297):1927-34

4188.   Tsuji M, Zavala F. Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites. Mol Immunol  2001 Dec;38(6):433-42

4189.   Urquiza M, Ocampo M, Patarroyo ME, Patarroyo MA. Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region. Mol Biochem Parasitol  2001 Oct;117(2):229-34

4190.   Yapabandara AM, Curtis CF, Wickramasinghe MB, Fernando WP. Control of malaria vectors with the insect growth regulator pyriproxyfen in a gem-mining area in Sri Lanka. Acta Trop  2001 Dec 21;80(3):265-76